Compare Zodiac Vent. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -14.27% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 8.10 times
Flat results in Mar 26
With ROCE of 3.6, it has a Expensive valuation with a 0.5 Enterprise value to Capital Employed
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commercial Services & Supplies
INR 14 Cr (Micro Cap)
8.00
36
6.10%
0.43
3.53%
0.31
Total Returns (Price + Dividend) 
Latest dividend: 0.1 per share ex-dividend date: Sep-23-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Zodiac Ventures Ltd Valuation Shifts Amid Prolonged Underperformance
Zodiac Ventures Ltd, a micro-cap player in the Commercial Services & Supplies sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer averages to assess the stock’s current price attractiveness.
Read full news article
Zodiac Ventures Ltd Valuation Shifts to Very Expensive Amidst Weak Returns
Zodiac Ventures Ltd, a micro-cap player in the Commercial Services & Supplies sector, has seen its valuation parameters deteriorate significantly, moving from expensive to very expensive territory. Despite a modest day change of 0.61%, the stock’s price-to-earnings (P/E) ratio and price-to-book value (P/BV) metrics reveal a stark contrast to its historical performance and peer group averages, raising concerns about its price attractiveness for investors.
Read full news article
Zodiac Ventures Ltd Valuation Shifts Amidst Prolonged Downtrend
Zodiac Ventures Ltd, a micro-cap player in the Commercial Services & Supplies sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects a deteriorating price attractiveness amid weak financial metrics and a challenging market backdrop, underscoring the stock’s continued underperformance relative to benchmarks and peers.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15-Jul-2026 | Source : BSEDear Sir Please find attached Certificate under regulation 74(5) of SEBI (DP) Regulation 2018.
Closure of Trading Window
27-Jun-2026 | Source : BSEIntimation of closure of Trading Window
Submission Of Reg 32- Statement Of Deviation And Variation.
30-May-2026 | Source : BSESubmission of Reg 32- Statement of Deviation and Variation.
Corporate Actions 
No Upcoming Board Meetings
Zodiac Ventures Ltd has declared 10% dividend, ex-date: 23 Sep 25
Zodiac Ventures Ltd has announced 1:10 stock split, ex-date: 21 Aug 14
No Bonus history available
Zodiac Ventures Ltd has announced 6:5 rights issue, ex-date: 18 Jul 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Ramesh Virji Shah (15.23%)
Niraj Rajnikant Shah (3.63%)
61.99%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -26.83% vs 86.36% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 96.88% vs 10.34% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 120.34% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 63.89% vs -36.84% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 94.62% vs 113.11% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 56.90% vs -6.45% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 114.38% vs 171.19% in Mar 2025
YoY Growth in year ended Mar 2026 is 52.48% vs 98.04% in Mar 2025






